Competitive NMDA antagonists enhance the catalepsy induced by Δ9-tetrahydrocannabinol in mice
References (10)
- et al.
Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen
Neuropharmacology
(1971) - et al.
Role of (NMDA) receptors in experimental catalepsy in rats
Life Sci.
(1990) - et al.
NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists
Eur. J. Pharmacol.
(1993) - et al.
Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice
Neuropharmacology
(1991) - et al.
Anticataleptic effects of the antagonist MK-801 in rats
Pharmacol. Biochem. Behav.
(1989)
There are more references available in the full text version of this article.
Cited by (5)
Motor actions of cannabinoids in the basal ganglia output nuclei
1999, Life SciencesNmda antagonists: Antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles
1995, Pharmacological ResearchEffects of opioids, cannabinoids, and vanilloids on body temperature
2011, Frontiers in Bioscience - ScholarN-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl) -6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia
2002, Journal of Pharmacology and Experimental Therapeutics
Copyright © 1994 Published by Elsevier Ireland Ltd.